In 2024, cancer therapy Perjeta's sales reached some 3.6 billion U.S. dollars. The highest growth in Perjeta's revenue over the period of seven years occurred in 2019, with a 27 percent increase compared to the previous year. This statistic depicts the total revenue of Roche's Perjeta worldwide from 2018 to 2024.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PharmaShots, & Roche. (January 30, 2025). Total revenue of cancer therapy Perjeta worldwide from 2018 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1453304/perjeta-global-revenue/
PharmaShots, und Roche. "Total revenue of cancer therapy Perjeta worldwide from 2018 to 2024 (in million U.S. dollars)." Chart. January 30, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1453304/perjeta-global-revenue/
PharmaShots, Roche. (2025). Total revenue of cancer therapy Perjeta worldwide from 2018 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1453304/perjeta-global-revenue/
PharmaShots, and Roche. "Total Revenue of Cancer Therapy Perjeta Worldwide from 2018 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Jan 2025, /statistics/1453304/perjeta-global-revenue/
PharmaShots & Roche, Total revenue of cancer therapy Perjeta worldwide from 2018 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1453304/perjeta-global-revenue/ (last visited July 24, 2026)
Total revenue of cancer therapy Perjeta worldwide from 2018 to 2024 (in million U.S. dollars) [Graph], PharmaShots, & Roche, January 30, 2025. [Online]. Available: /statistics/1453304/perjeta-global-revenue/
